By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
It has been a mixed year for Dexcom Inc insiders: $1 million bought by one person and $12.6 million sold by nine, so more selling than buying overall.
Biggest single buyer: Leach Jacob Steven, COO, with roughly $863,000. That includes C-suite money, which tends to get the most attention.
DXCM also shows up in congressional disclosures: 10 reported trades from five lawmakers in two years. On the institutional side, 970 funds reported holding DXCM at the end of Q2 2026, and more funds bought than sold. Looking at the quarterly pattern: 3 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
Are insiders buying or selling DXCM stock?
In the last 12 months Dexcom Inc insiders made open-market purchases worth about $1 million and sales worth about $12.6 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in DXCM?
The most recent open-market insider trade in DXCM was filed on 2026-09-30.
How many institutions own DXCM?
970 investment managers reported holding DXCM in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded DXCM?
Yes. Members of Congress reported 10 trades in DXCM over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).